Topic highlights include: Mayo Clinic Health System turns 30, Doctors say now is time to get flu shot, White House releases strategy for ending hunger in US by 2030

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice cover current trends for monkeypox and COVID-19, their thoughts as autumn begins, getting back to infection prevention basics, and a quick legislation update.

PACE / State of CA / State of FLThis “phlebotomy webinar” will address the evidence behind blood diversion as a mechanism to lower blood culture contamination rates and discuss the experience at Mayo Clinic Rochester with a pilot of one blood diversion device.

Due to hurricane Ian, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.

In an effort to eliminate interpretation mistakes and in turn improve diagnosis and treatment options for patients who have kidney stones, a team of researchers from Mayo Clinic’s Department of Laboratory Medicine and Pathology recently conducted a 12-month study to determine whether the use of artificial intelligence-trained algorithms can find errors in manually reviewed and reported kidney stone composition results.

PACE / State of CA / State of FL

This week's research roundup features: Robotics in neurosurgery: current prevalence and future directions

PACE / State of CA / State of FLThis “Continual Improvement” webinar will provide an overview of new or changed regulations for 2022, and other regulatory issues that have the potential to affect clinical laboratories. The latter half of the year has been very busy for laboratory-related regulations and legislation, including the potential VALID Act and its impact to laboratory developed tests (LDTs), the SALSA Act which seeks to address reimbursement issues with the Protecting Access to Medicare Act (PAMA), and the potential end of the COVID-19 public health emergency.

Lisa Brown, quality specialist for Mayo Clinic Laboratories customer service, explains working "behind the scenes" when a client calls Mayo Clinic Laboratories with an inquiry, that call is typically picked up within 20 seconds by an agent from Mayo Laboratory Inquiry (MLI). There are no phone trees or automated menus to wade through before they reach an agent. Agents mind the phones 24/7, 365 days a year.

Topic highlights include: White House launches monkeypox research agenda, Mayo Clinic: collaborations, startups to drive innovation, Why the latest screening tests and treatments offer hope for ovarian cancer

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the Saving Access to Laboratory Services Act (SALSA), how it is designed to mitigate harmful effects of the Protecting Access to Medicare Act (PAMA), where the legislation stands today, and how to get involved in advocacy.

Connie Ohnstad is the supervisor for Mayo Clinic Laboratories Inventory, which includes Mayo Clinic Laboratories Packaging and Specimen Kit Orders (SKO). Connie wears many hats as a supervisor at MCL, and she has a long history with Mayo Clinic, which has employed several generations of Connie’s family. She takes pride in ensuring that every day she offers her best for her employees, patients, and clients.

This week's research roundup features: Into the future: a pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer

Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, they discuss Dr. Morice’s new role as CEO and president of Mayo Clinic Laboratories (MCL), his patient-centered vision for the future, and how MCL is leading positive changes in the diagnostics industry.